We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a ...

Pediatric COVID-19 severity appears to be declining among hospitalized children as Omicron subvariants evolve.

The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...

Researchers identify genetic mutation in small group of people who developed the serious disorder after receiving the AstraZeneca or Johnson & Johnson vaccine.

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Moderna’s updated COVID-19 mRNA vaccine, Spikevax targeting the SARS-CoV-2 LP.8.1 variant, for adults and children aged ...

Cognitive complaints are among the most common and debilitating symptoms of post-COVID condition. Researchers at the Central ...

In its main clinical trial, mRNA-1010 was shown to be 26.6% more effective than the comparator flu shot in adults aged 50 ...

Fact Check - Pandemic simulations are conducted for preparedness, not as a blueprint for engineering a new global crisis.

Scientists have mapped how genetics and life experiences leave lasting epigenetic marks on immune cells. The discovery helps ...

According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...